A discovery from Australian researchers could lead to better treatment for children with neuroblastoma, a cancer that ...

New research has identified a drug combination that can bypass the cellular defences of neuroblastoma that lead to relapse.

Scientists have discovered a drug combo that may bypass tumor defenses, offering new hope for children with high-risk ...

According to Australia’s Garvan Institute of Medical Research, the drug combination can bypass the cellular defences these ...

However, researchers at the Garvan Institute have found a drug called romidepsin can help reduce tumour growth and the chances of the deadly cancer returning, helping more children survive.

Discovered in the 1990s, the JNK protein, or, to give it its full name, c-Jun NH 2-terminal kinase, was found to be the protein kinase responsible for the phosphorylation of c-Jun at Ser-63 and Ser-73 ...

Morphologic and genomic characterization of circulating tumor cells in patients with metastatic colorectal cancer treated with combinational treatment of andecaliximab, bevacizumab and chemotherapy.